Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Governance

CKB staff

The principal investigators of the CKB are Professor Liming Li (PKU) and Professor Zhengming Chen (Oxford). Their work and that of their teams and collaborating partners in Oxford and Beijing is supported by a number of governance committees. Additional working groups are convened to assist with the day-to-day operations of the study.

Key Committees

CKB STEERING COMMITTEE

Responsible for the overall leadership, strategic development and management of the study.

INTERNATIONAL SCIENTIFIC ADVISORY COMMITTEE BOARD

The Board provides advice, support and guidance to the CKB Steering Committee and principal investigators on the study’s scientific direction, strategy and operations.

  • Co-chairs: Professor David Hunter (University of Oxford), Professor Qimin Zhan (Peking University Health Science Center) 

RESEARCH MANAGEMENT COMMITTEE

The Research Management Committee helps coordinate, manage, and monitor the combined research activities of the ICC, the NCC, and their collaborators. It oversees open data access procedures and management.

INDEPENDENT ACCESS COMMITTEE

The Independent Access Committee provides oversight and guidance on data access issues, monitors the progress of all data requests, and reviews any requests that raise particular issues (such as those relating to the use of samples).

  • Membership: Professor Judith Mackay, Hong Kong; Professor Peter Sandercock, University of Edinburgh; Professor Michael Parker, Ethox Centre, Oxford Population Health; Jonathan Sellors, Legal Counsel, UK Biobank

For further details of the terms of reference and committee membership email the CKB team.